Prime Medicine PRME Balance Sheet (2021-2026)

NASDAQ PRME
$3.70 -0.01 (-0.27%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Prime Medicine Quarterly Balance Sheet

Periods 20 quarters
Latest Jun 2026

Prime Medicine reported total assets of $249.04M and total liabilities of $209.23M for the quarter ended Jun 2026, down 10.7% year over year. This balance sheet covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 200.66M185.42M164.25M92.24M47.95M187.62M133.46M120.58M43.96M41.57M94.16M55.60M117.98M182.48M91.88M53.80M71.40M63.03M64.11M47.45M
Receivables - NetNet Receivables 55.00M0.02M0.12M4.59M
Receivables 55.00M0.02M0.12M4.59M
Prepaid Assets 0.96M2.18M2.45M3.98M10.87M19.21M19.06M4.20M4.20M9.54M14.67M16.54M16.39M15.63M2.94M1.97M1.36M
Current Assets 270.58M148.84M296.62M253.50M218.49M184.53M142.98M217.65M170.80M246.07M211.89M163.76M121.29M231.41M181.29M137.89M96.80M
Non-Current Assets
Property, Plant & Equipment (Net) 4.93M14.97M19.01M21.59M20.56M22.03M22.66M23.93M23.81M23.29M24.40M24.96M23.83M22.05M20.57M18.82M17.08M
Other Non-Current Assets 13.12M13.12M13.50M13.50M13.50M13.50M13.50M13.50M13.50M13.50M13.50M14.06M14.06M14.06M13.69M13.69M13.69M13.69M13.69M
Non-Current Assets 31.28M66.42M63.70M63.45M62.38M54.61M50.88M93.73M88.90M86.71M85.62M164.40M157.72M153.61M161.44M156.84M152.24M
Assets 301.86M215.26M360.31M316.95M280.87M239.15M193.85M311.38M259.70M332.78M297.51M328.16M279.01M385.01M342.73M294.73M249.04M
Liabilities
Current Liabilities
Accounts Payables 1.44M4.11M4.33M4.56M5.49M14.12M19.54M10.08M4.64M5.43M11.35M10.03M6.38M9.35M8.89M12.32M5.81M
Payables 1.44M4.11M4.33M4.56M5.49M14.12M19.54M10.08M4.64M5.43M11.35M10.03M6.38M9.35M8.89M12.32M5.81M
Accumulated Expenses 37.19M6.53M10.69M7.54M9.72M14.02M14.11M7.61M10.89M18.68M15.90M9.19M12.16M11.00M12.60M8.10M8.98M
Current Leases 7.34M11.58M11.69M11.77M13.51M11.22M9.28M6.75M5.22M4.48M3.61M6.86M7.26M7.71M8.14M8.55M8.97M
Current Deferred Revenue 9.28M7.09M8.21M8.31M6.95M7.82M7.32M7.93M
Total Current Liabilities 57.98M22.22M26.71M23.87M28.72M39.37M56.42M24.44M20.75M37.88M37.96M34.29M34.11M35.02M37.45M36.29M31.69M
Non-Current Liabilities
Non-Current Deffered Revenue 62.64M63.22M60.66M59.56M59.75M58.13M57.77M56.03M
Preferred Stock Liabilities 199.64M395.80M199.64M199.64M395.80M
Operating Leases 3.07M31.44M17.05M25.96M25.44M17.04M4.36M43.79M41.58M41.25M37.18M121.15M119.74M118.14M108.29M114.51M112.48M
Non-Current Deferred Tax Liability 5.97M0.48M8.75M0.08M0.11M0.13M
Other Non-Current Liabilities 6.00M6.00M6.00M6.00M12.00M12.00M18.00M18.00M18.00M18.00M
Total Non-Current Liabilities 60.78M61.62M57.12M137.28M138.36M209.24M206.15M205.19M203.87M200.03M191.23M
Total Liabilities 94.42M62.30M166.94M195.06M42.56M44.04M38.15M40.76M45.19M60.78M67.62M63.12M143.28M144.36M221.24M218.15M223.19M221.87M218.03M209.23M
Shareholder's Equity
Common Equity -94.42M-156.24M-166.94M-195.06M-223.10M316.27M278.80M240.10M193.96M133.07M243.77M196.59M189.50M153.15M106.92M60.86M161.82M120.87M76.70M39.81M
Liabilities and Shareholders Equity 301.86M215.26M360.31M316.95M280.87M239.15M193.85M311.38M259.70M332.78M297.51M328.16M279.01M385.01M342.73M294.73M249.04M
Retained Earnings -171.38M-253.91M609.85M611.60M615.35M619.79M624.41M780.95M789.08M834.42M840.36M846.04M852.56M1,004.06M1,009.14M1,014.17M1,019.40M
Treasury Shares 115.76M161.42M115.76M115.76M161.42M